L
ISSUER//CIK 0000920465
LA JOLLA PHARMACEUTICAL CO
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 10-Q/A1.3 MBLA JOLLA PHARMACEUTICAL COSep 12, 3:44 PM ET·0000950123-11-083977
- 48.1 KBLA JOLLA PHARMACEUTICAL COAug 4, 5:52 PM ET·0001181431-09-037776
- 45.9 KBLA JOLLA PHARMACEUTICAL COMay 11, 2:12 PM ET·0001209191-07-029583
- 36.2 KBLA JOLLA PHARMACEUTICAL COMay 10, 6:01 PM ET·0001209191-07-029462
- 8-K61.4 KBLA JOLLA PHARMACEUTICAL COMay 10, 5:13 PM ET·0001299933-07-002960
- 10-Q159.7 KBLA JOLLA PHARMACEUTICAL COMay 9, 3:45 PM ET·0000936392-07-000396
- 48.6 KBLA JOLLA PHARMACEUTICAL COFeb 7, 6:48 PM ET·0001209191-07-008430
- 413.4 KBLA JOLLA PHARMACEUTICAL COFeb 7, 6:47 PM ET·0001209191-07-008429
- 49.4 KBLA JOLLA PHARMACEUTICAL COFeb 7, 6:46 PM ET·0001209191-07-008428
- 412.5 KBLA JOLLA PHARMACEUTICAL COFeb 7, 6:45 PM ET·0001209191-07-008426
Insiders
10- ADAMS THOMAS PHDDirector
- BENNETT BRUCE K JRVP of Manufacturing
- Elchico Josefina TVP Quality Operations
- ENGBERS WILLIAMDirector
- ENGLE STEVEN BDirector, CEO & Chairman
- FILDES ROBERT PHDDirector
- Gillespie DeirdreDirector, President & CEO
- Gonzalez Alejandro10% Owner
- HEILBRUNN KENNETH RVP of Clinical Development
- JENN PAULVP of Product Development
Tickers
No tickers on record
Addresses
business
201 JONES ROAD, SUITE 400
WALTHAM, MA, 02451
mailing
201 JONES ROAD, SUITE 400
WALTHAM, MA, 02451